TherapeuticsMD (TXMD) Other Non-Current Liabilities (2012 - 2026)

TherapeuticsMD has reported Other Non-Current Liabilities for 9 years, with the latest figure at $873000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 9.81% year-over-year to $873000.0; the trailing twelve-month figure through Mar 2026 stood at $873000.0 (up 9.81% YoY), and the FY2025 full-year result was $873000.0, up 17.34% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $873000.0, roughly flat from $873000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $1.2 million in Q1 2022, with the low at $554000.0 in Q2 2022.
• Historically, Other Non-Current Liabilities has averaged $854764.7 across 5 years, with a median of $832000.0 in 2025.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities sank 48.25% — and 2023, when it jumped 114.62%.
• TherapeuticsMD's Other Non-Current Liabilities stood at $1.1 million in 2022, then plunged by 42.55% to $636000.0 in 2023, then increased by 16.98% to $744000.0 in 2024, then grew by 17.34% to $873000.0 in 2025, then changed by 0.0% to $873000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $873000.0 (Q1 2026), $873000.0 (Q4 2025), and $871000.0 (Q3 2025), per Business Quant data.